Error: Twitter did not respond. Please wait a few minutes and refresh this page.
Tag Archives: Bosulif
Like Pfizer’s Bosulif, newly approved Synribo (from Teva Pharmaceuticals) gives CML patients options. As I mentioned in my September post about Bosulif, CML patients have a specific type of genetic mutation called the Philadelphia chromosome. This mutation causes bone marrow to make an enzyme … Continue reading